欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Ziresovir_1422500-60-4_产品详情
1422500-60-4
  • names:

    Ziresovir

  • CAS号:

    1422500-60-4

    MDL Number:
  • MF(分子式): C22H25N5O3S MW(分子量): 439.53
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Ziresovir
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM000868-5mg 5mg 99.86% ¥ 4725.00 ¥ 4725.00 2-3天
- +
¥ 0.00
YZM000868-1mg 1mg 99.86% ¥ 1560.00 ¥ 1560.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 RO-0529 ;AK0529
英文别名 Ziresovir
CAS号 1422500-60-4
Inchi
InchiKey
分子式 Formula C22H25N5O3S
分子量 Molecular Weight 439.53
溶解度Solubility 生物体外In Vitro:DMSO溶解度125 mg/mL(284.39 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
产品说明
IntroductionZiresovir (AK0529;RO529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows antiSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species.
Application1
Application2
Application3
Ziresovir (AK0529; RO-0529) 是一种有效的口服有效的,选择性呼吸道合胞病毒 (RSV) 融合 (F) 蛋白 (RSV F) 抑制剂。 Ziresovir 显示抗 RSV 活性 (EC50=3 nM), 并具有药代动力学表现。
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir shows anti-RSV activity (EC50=3 nM) and highlights pharmacokinetics in animal species.

Ziresovir, also known as RO-0529 and AK0529, is the first time as a promising respiratory syncytial virus (RSV) fusion (F) protein inhibitor that currently is in phase 2 clinical trials. RO-0529 demonstrates single-digit nM EC50 potency against laboratory strains, as well as clinical isolates of RSV in cellular assays, and more than one log viral load reduction in BALB/c mouse model of RSV viral infection. RO-0529 was proven to be a specific RSV F protein inhibitor by identification of drug resistant mutations of D486N, D489V, and D489Y in RSV F protein and the inhibition of RSV F protein-induced cell−cell fusion in cellular assays.

警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Scott SA, et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol. 2009 Feb;5(2):108-17.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents